Ergomed plc (ERGO.L) LSE

1,348.00

+2(+0.15%)

Updated at November 10, 2023 04:29PM

Currency In GBp

Ergomed plc

Address

Surrey Research Park

Guildford, GU2 7HJ

United Kingdom of Great Britain and Northern Ireland

Phone

44 1483 503 205

Sector

Healthcare

Industry

Biotechnology

Employees

1400

First IPO Date

July 15, 2014

Key Executives

NameTitlePayYear Born
Mr. Michael William SpiteriChief Transformation & Technology Officer52,7691961
Mr. Richard T. BarfieldChief Financial Officer & Executive Director438,7831958
Dr. Miroslav ReljanovicFounder & Executive Chairman964,2961959
Mr. Shaun HopgoodChief Information Officer0N/A
Jonathan CurtainChief Financial Officer & Executive Director0N/A
Jonathan Andrew CurtainChief Financial Officer & Executive Director01976
Dr. Michael ForstnerHead of Risk Management & Pharmacoepidemiology0N/A
Ms. Sally AmanuelPres of PrimeVigilance0N/A
Dr. Gordana TonkovicPres of Clinical Research0N/A
Ms. Ronel SteynSenior Vice President of Global Devel.0N/A
Keith ByrneSenior Vice-Pres of Capital Markets & Strategy0N/A
Joanne BletcherCompany Sec.0N/A

Description

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.